The andrologist's contribution to a better life for ageing men: part 1. (Q40513531)

21 September 2017

title

The andrologist's contribution to a better life for ageing men: part 1. (English)

1 reference

21 September 2017

F Comhaire

1 reference

21 September 2017

A Mahmoud

series ordinal

1 reference

21 September 2017

publication date

22 September 2015

1 reference

21 September 2017

1 reference

21 September 2017

1 reference

21 September 2017

1 reference

21 September 2017

page(s)

87-98

1 reference

Risks and benefits of hormonal manipulation as monotherapy or adjuvant treatment in localised prostate cancer

21 September 2017

cites work

1 reference

Spray-dried Amioca starch/Carbopol 974P mixtures as buccal bioadhesive carriers

21 January 2018

1 reference

Associations between sex steroids and the development of metabolic syndrome: a longitudinal study in European men.

21 January 2018

1 reference

Risk of Myocardial Infarction in Older Men Receiving Testosterone Therapy.

21 January 2018

1 reference

Dehydroepiandrosterone (DHEA), DHEA sulfate, and aging: contribution of the DHEAge Study to a sociobiomedical issue

21 January 2018

1 reference

Cardiovascular risks and elevation of serum DHT vary by route of testosterone administration: a systematic review and meta-analysis

21 January 2018

1 reference

Andropause: hormone replacement therapy in the ageing male

21 January 2018

1 reference

Plasma Testosterone in Patients with Varicocele and Sexual Inadequacy

21 January 2018

1 reference

Hypogonadism as a risk factor for cardiovascular mortality in men: a meta-analytic study

21 January 2018

1 reference

Estrogens in the Treatment of Prostate Cancer

21 January 2018

1 reference

Effects of two low-dose oral contraceptives containing ethinylestradiol and either desogestrel or levonorgestrel on serum lipids and lipoproteins with particular regard to LDL size

21 January 2018

1 reference

Metabolic diseases and sex hormone levels affect differently in the development of cardiovascular and cerebrovascular diseases in elderly males

21 January 2018

1 reference

Cardiovascular disease in transsexual persons treated with cross-sex hormones: reversal of the traditional sex difference in cardiovascular disease pattern

21 January 2018

1 reference

Adverse effects of testosterone replacement therapy: an update on the evidence and controversy

21 January 2018

1 reference

Low Testosterone in Men with Type 2 Diabetes: Significance and Treatment

21 January 2018

1 reference

Late-onset hypogonadism: current concepts and controversies of pathogenesis, diagnosis and treatment

21 January 2018

1 reference

Low free testosterone predicts mortality from cardiovascular disease but not other causes: the Health in Men Study

21 January 2018

1 reference

Contraceptives containing desogestrel or levonorgestrel have different effects on serum lipoproteins and post-heparin plasma lipase activities

21 January 2018

1 reference

The estrogenic burden on vascular risk in male-to-female transsexuals

21 January 2018

1 reference

The androgen-regulated protease TMPRSS2 activates a proteolytic cascade involving components of the tumor microenvironment and promotes prostate cancer metastasis.

21 January 2018

1 reference

Low serum testosterone and increased mortality in men with coronary heart disease

21 January 2018

1 reference

Androgens and sexual function: a placebo-controlled, randomized, double-blind study of testosterone vs. dehydroepiandrosterone in men with sexual dysfunction and androgen deficiency

21 January 2018

1 reference

Testosterone deficiency is associated with increased risk of mortality and testosterone replacement improves survival in men with type 2 diabetes

21 January 2018

1 reference

Obesity and age as dominant correlates of low testosterone in men irrespective of diabetes status.

21 January 2018

1 reference

Testosterone and the cardiovascular system: a comprehensive review of the clinical literature

21 January 2018

1 reference

Effect of 1-year oral administration of dehydroepiandrosterone to 60- to 80-year-old individuals on muscle function and cross-sectional area: a double-blind placebo-controlled trial.

21 January 2018

1 reference

Late-onset hypogonadism and mortality in aging men.

21 January 2018

1 reference

Prostate-specific antigen (PSA) concentrations in hypogonadal men during 6 years of transdermal testosterone treatment

21 January 2018

1 reference

Influence of demographic factors and biochemical characteristics on the prostate-specific antigen (PSA) response to testosterone replacement therapy

21 January 2018

1 reference

5-alpha-reductase activity and risk of prostate cancer among Japanese and US white and black males

21 January 2018

1 reference

Insights into the mechanism of organ-specific cancer metastasis

21 January 2018

1 reference

Evidence based medicine: what it is and what it isn't

21 January 2018

1 reference

Role of DHEA in cardiovascular diseases

21 January 2018

1 reference

High hematocrit as a risk factor for venous thrombosis. Cause or innocent bystander?

21 January 2018

1 reference

Osteoporosis in male hypogonadism: responses to androgen substitution differ among men with primary and secondary hypogonadism

21 January 2018

1 reference

Testosterone treatment and mortality in men with low testosterone levels.

21 January 2018

1 reference

Testosterone and dihydrotestosterone and incident ischaemic stroke in men in the Cardiovascular Health Study

21 January 2018

1 reference

Testosterone, dihydrotestosterone, and incident cardiovascular disease and mortality in the cardiovascular health study

21 January 2018

1 reference

Health in an ageing world--what do we know?

21 January 2018

1 reference

Androgen receptor: structure, role in prostate cancer and drug discovery

21 January 2018

1 reference

Dehydroepiandrosterone (DHEA)--a precursor steroid or an active hormone in human physiology

21 January 2018

1 reference

Comparative assessment in young and elderly men of the gonadotropin response to aromatase inhibition

21 January 2018

1 reference

Buccal absorption of testosterone and its esters using a bioadhesive tablet in dogs

21 January 2018

1 reference

Dehydroepiandrosterone (DHEA) replacement decreases insulin resistance and lowers inflammatory cytokines in aging humans

21 January 2018

1 reference

Dehydroepiandrosterone replacement therapy in older adults improves indices of arterial stiffness

21 January 2018

1 reference

Identification of late-onset hypogonadism in middle-aged and elderly men.

21 January 2018

1 reference

Changes in serum sex hormone profiles after short-term low-dose administration of dehydroepiandrosterone (DHEA) to young and elderly persons

21 January 2018

1 reference

Long-term testosterone treatment in elderly men with hypogonadism and erectile dysfunction reduces obesity parameters and improves metabolic syndrome and health-related quality of life

21 January 2018

1 reference

In older men an optimal plasma testosterone is associated with reduced all-cause mortality and higher dihydrotestosterone with reduced ischemic heart disease mortality, while estradiol levels do not predict mortality.

21 January 2018

1 reference

IPASS: a study on the tolerability and effectiveness of injectable testosterone undecanoate for the treatment of male hypogonadism in a worldwide sample of 1,438 men.

21 January 2018

1 reference

Androgen Deprivation Therapy and the Risk of Coronary Heart Disease and Heart Failure in Patients with Prostate Cancer

21 January 2018

1 reference

Effects of oral testosterone undecanoate therapy on bone mineral density and body composition in 322 aging men with symptomatic testosterone deficiency: a 1-year, randomized, placebo-controlled, dose-ranging study

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/AND.12485

1 reference

21 September 2017

1 reference